HLA-DRB1*0301 and DQA1*0501 in RA.
Gunnarsson
I
I
Ringertz
B
B
Bratt
J
J
Sundelin
B
B
D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000235:genetics*; D001310:Auranofin / Q000009:adverse effects; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced; D006683:HLA-DQ Antigens / Q000235:genetics*; D059848:HLA-DQ alpha-Chains; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008297:Male; D008875:Middle Aged
D018501:Antirheumatic Agents; D006683:HLA-DQ Antigens; D059848:HLA-DQ alpha-Chains; C069050:HLA-DQA1 antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C553502:HLA-DRB1*03:01 antigen; D001310:Auranofin